A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer.

Cohen, Alexander T; Wallenhorst, Christopher; Choudhuri, Satarupa; Nassar, Ayman; Pollock, Kevin G; Martinez, Carlos

Cohen, Alexander T; Wallenhorst, Christopher; Choudhuri, Satarupa; Nassar, Ayman; Pollock, Kevin G; Martinez, Carlos.

Afiliação

Cohen AT; Department of Haematology, Guy's and St Thomas' Hospitals, NHS Foundation Trust, King's College London, London, United Kingdom.
Wallenhorst C; Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany.
Choudhuri S; Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom.
Nassar A; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, Middlesex, United Kingdom.
Pollock KG; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, Middlesex, United Kingdom.
Martinez C; Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany.

Thromb Haemost ; 124(4): 324-336, 2024 Apr.

Article em En | MEDLINE | ID: mdl-37527782

Assuntos

Neoplasias; Tromboembolia Venosa; Masculino; Feminino; Humanos; Tromboembolia Venosa/tratamento farmacológico; Hemorragia/induzido quimicamente; Anticoagulantes/uso terapêutico; Fatores de Risco; Neoplasias/complicações

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google